<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Nature Network - Notices from Immunology</title>
    <link>http://network.nature.com/group/immunology</link>
    <description>Latest group notices from the administrators of Immunology</description>
    <language>en-us</language>
    <ttl>40</ttl>
    <item>
      <title>NanoImmunology Begins: a Nanomaterials-based Therapeutic Approach to Treat Allergy</title>
      <pubDate>Tue, 26 Jun 2007 22:55:52 -0000</pubDate>
      <link>http://network.nature.com/groups/immunology/notice/2007/06/26/nanoimmunology-begins-a-nanomaterials-based-therapeutic-approach-to-treat-allergy</link>
      <guid>http://network.nature.com/groups/immunology/notice/2007/06/26/nanoimmunology-begins-a-nanomaterials-based-therapeutic-approach-to-treat-allergy</guid>
      <description>
        <![CDATA[<p>Researchers from Luna Innovations Incorporated (NASDAQ: <span class="caps">LUNA</span>) and Virginia Commonwealth University (VCU) are the first to show that carbon nanospheres, sometimes referred to as &#8220;buckyballs,&#8221; are able to block allergic response in human cell culture experiments and mice. <br /><a href="http://ir.lunainnovations.com/phoenix.zhtml?c=196907&#38;p=irol-newsArticle2&#38;ID=1017409&#38;highlight"><img src="http://media.corporate-ir.net/media_files/IROL/19/196907/images/vcu.jpg" alt="" /></a>=<br /><a href="http://ir.lunainnovations.com/phoenix.zhtml?c=196907&#38;p=irol-newsArticle2&#38;ID=1017409&#38;highlight">Read Full Story here</a>=</p>]]>
      </description>
    </item>
  </channel>
</rss>
